One interesting idea is a “one-two punch”: use a DNMT inhibitor to demethylate and expose cancer-testis antigens or viral elements, then radiotherapy not only kills cells but also releases neoantigens from those now-expressed elements to stimulate immunity against the tumor. The gene discussed is DNMT1; the disease is neoplasm.